Clinical Trials Sponsored by Infectious Diseases Physicians, Inc.

Total 264 results

Infectious Diseases Physicians, Inc.
Johns Hopkins University

Completed

Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

Prosthetic Joint Infection | Osteomyelitis | Septic Arthritis | Bone Infection | Joint Infection

United States
Centre for Infectious Disease Research in Zambia
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Causes of Rotavirus Vaccine Failure in Zambian Children

Diarrhoea

Zambia
Spanish Network for Research in Infectious Diseases

Completed

Proadrenomedullin and Copeptin in Patients With Septic Shock (proADM)

Septic Shock

Spain
Spanish Network for Research in Infectious Diseases

Completed

Adverse Events in the Tracheal Intubation in the Intensive Care Unit (INTUPROS)

Intubation | Intubation Complication | Intubation; Difficult or Failed

Spain
Spanish Network for Research in Infectious Diseases
European Society of Clinical Microbiology and Infectious Diseases

Completed

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. (INCREMENT-SOT)

Pathologic Processes | Sepsis | Systemic Inflammatory Response Syndrome | Inflammation | Bacterial Infections | Bacteremia | Infection | Organ Transplantation | Clinically Significant Bacteremia

Spain
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
GeoVax, Inc.

Completed

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
ModernaTX, Inc.

Completed

Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults

COVID-19 | COVID-19 Immunisation

United States
National Institute of Allergy and Infectious Diseases...
ModernaTX, Inc.

Completed

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)

COVID-19 | COVID-19 Immunisation

United States
Crestone, Inc
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Clostridioides Difficile Infection

United States, Canada
Cellex, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Clinical Evaluation of QFlu Combo Test (QFlu)

Fatigue | Myalgia | Cough | Fever | Headache | Nasal Obstruction | Sore Throat

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

HIV Infections

United States
Centre for Infectious Disease Research in Zambia

Recruiting

Validation of Artificial Intelligence Enabled TB Screening and Diagnosis in Zambia

Tuberculosis

Zambia
FluGen Inc
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Influenza Vaccine

United States
CytoDyn, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

PRO 140 by IV Administration in Adults With HIV-1 Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns

HIV Infections | Pregnancy

United States
Shionogi
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)

SARS-CoV-2 Infection

United States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-5024 Safety and PK in Healthy Adult Volunteers

Healthy Subjects

Netherlands
Melinta Therapeutics, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (SOLITAIRE-U)

Uncomplicated Urogenital Gonorrhea

United States, Australia
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers

Bacterial Infections

United States
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function

Pharmacokinetics

United States
National Institute of Allergy and Infectious Diseases...
Gritstone bio, Inc.

Completed

Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults

COVID-19

United States
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-7145 Drug-Drug Interaction in Healthy Adult Volunteers

Healthy Subjects

Netherlands
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers

Healthy Volunteers

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Biocine

Completed

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Biocine

Completed

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

HIV Infections | HIV Seronegativity

United States, Puerto Rico
Syntrix Biosystems, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis

Psoriasis

United States
Ansun Biopharma, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

DAS181 Single Dose Escalation Study in Healthy Adults

Healthy

United States
Ansun Biopharma, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Single Dose Escalating Study of DAS181 in Adults

Influenza

United States
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants

Pharmacokinetics

United States
Najit Technologies, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Trial of an Inactivated Yellow Fever Virus Vaccine

Yellow Fever

United States
Syntrix Biosystems, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis

Psoriasis

United States
Navigen, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); Covance

Completed

A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers

HIV Infections

United States
Venatorx Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers

Bacterial Infections

United States
Ina-Respond
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia (INAPROACTIVE)

HIV

Indonesia
National Institute of Allergy and Infectious Diseases...
ViiV Healthcare; Mylan Inc.

Recruiting

Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis

HIV-associated Tuberculosis

South Africa, Thailand
National Institute of Allergy and Infectious Diseases...
ImmunityBio, Inc.; Rockefeller University

Recruiting

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

HIV Infection

United States
National Institute of Allergy and Infectious Diseases...
North American Biologicals Inc

Completed

A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children

HIV Infections

United States, Puerto Rico
Nicholaos C Bellos, MD
GlaxoSmithKline

Completed

Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients

Drug-induced Hypotension
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Glaxo Wellcome

Completed

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

HIV Infections

United States
JESUS RODRIGUEZ BAÑO

Completed

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study (INCREMENT)

Clinically Significant Bacteremia

Spain
National Institute of Allergy and Infectious Diseases...
Otsuka Pharmaceutical Development & Commercialization, Inc.

Recruiting

Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB

HIV Infections | Tuberculosis

Tanzania, India, South Africa, Botswana
National Institute of Allergy and Infectious Diseases...
Novartis Vaccines and Diagnostics, Inc

Completed

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.

Completed

COVID-19: Human Epidemiology and Response to SARS-CoV-2 (HEROS)

SARS-CoV-2 | Coronavirus Disease 2019 (COVID-19)

United States
International Partnership for Microbicides, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women

Human Immunodeficiency Virus

United States

Clinical Trials Sponsored by Infectious Diseases Physicians, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations